3D Bioprinting Market

3D Bioprinting involves the layer-by-layer deposition of living cells in combination with biocompatible and degradable materials known as Bioink, to create predefined and complicated tissue constructs. The process starts with the extraction of stem cells from a patient or a healthy donor, after the cell differentiation into the target cell type the cultured cells are mixed with Bioink and used with the appropriate Bioprinter type to create predesigned tissue structures.

The global 3D Bioprinting Market was valued at $343.20 million in 2020 and is estimated to reach $1,535.77 million by 2028, registering a CAGR of 20.60% from 2021 to 2028.

Based on the ability of 3D bioprinting to use stem cells including iPSC and MSC to develop tissue constructs of any desirable cell types such as heart, liver, neuronal and pancreatic cells. 3D Bioprinting technology has shown tremendous potential for disease modeling, toxicology testing, personalized diagnostics, and tissue & organ regeneration.

Factors that drive the market growth involve, (1) an increase in technological advancements and innovation, (2) a rise in the number of chronic diseases, (3) an increase in government and private R&D investment, (4) and an increase in the usage of 3D Bioprinted human skin models in dermatological and cosmetics product testing.

However, high costs associated with the process, ethical issues, and lack of skilled professionals might hamper the market growth.

The report also presents a detailed quantitative analysis of the current market trends and future estimations from 2021 to 2028.

The forecasts cover 5 Technology Types, 4 Application Types, 4 Material Types, 4 Regions, and 14 Countries.

The report comes with an associated file covering quantitative data from all numeric forecasts presented in the report.

The report has the following key findings:

• The global 3D Bioprinting market was valued at US$ 343.20 Mn, in 2020, and is forecast to be valued at US$ 1,535.77 Mn, by the end of 2028, expanding at a CAGR of 20.6%, during the forecast period.

• The North American region accounts for nearly 40% of the global 3D Bioprinting market.

• The global 3D Bioprinting market is expected to have a largely positive outlook, over the forecast period, with emerging economies such as India, China, Brazil, Japan, and Israel projected to register good CAGRs during the forecast period.

• Among the Application type, Tissue & Organ Regeneration is expected to continue its dominance throughout the forecast period.

• Among the Technology Type, Inkjet Bioprinting Segment is anticipated to account for the largest market share during the forecast period.

• Among the Material, Biomaterials is estimated to dominate the market throughout the forecast period.

The report covers the following topics:

• Market Drivers, Restraints, and Opportunities

• Analysis of by Technology Type, Application, Material, and Region

• 15 Company Profiles, Product Portfolio, and Key Strategies

• COVID19 Impact on 3D Bioprinting Industry

• Market analysis and forecast from 2021 to 2028